Launch Excellence 2020

Blue Latitude Health|18th November 2019

In the past year, the competition in biosimilars and complex generics has complicated the launch landscape. An abundance of discoveries coupled with radically evolving stakeholder needs is also straining the traditional pharmaceutical launch.

In this special pack, we provide a comprehensive outlook of launch excellence. We cover topics ranging from gathering effective insights, to understanding the current landscape, and the importance of pre-launch strategy for improving relationships between the customer and the brand.

The report also features interviews with key players such as organisational transformation expert Philip Atkinson. He shares his unique perspective on the importance of structuring agile organisational change to help pharmaceutical companies adapt and stay competitive.

These articles are complemented by case studies curated by our experienced in-house team.

In this publication, we help you answer the following questions:

  • Are you prepared for a successful launch?

  • How can you use insights to understand customers decision-making behaviour?

  • What are you missing in your CAR-T service launch?

  • How do you stay competitive with a lean pharmaceutical launch?

  • Multi-indication launches - how do you navigate in this space? 

Our content has moved

Blue Latitude Health|18th November 2020

We’re posting all new articles on our parent website fishawack.com

read more

Fishawack Health launches Delta Magazine

Blue Latitude Health|17th November 2020

Our parent company Fishawack Health has launched a new magazine with a first issue unpacking rare disease.

read more

In the precision medicine era, the line between products and services is blurred

Amit Sheinholtz and Ilektra Safari|27th August 2020

Precision and personalised medicines are more than products, they are services in their own right. So, how should pharma approach this uncharted territory to ensure targeted therapies work for patients?

read more